$PCRX
Pacira Biosciences Inc Stock $pcrx

$pcrx Overview Financials Valuation SEC Filings Company Website

2017 Form 10-K Financial Statement

#000139681418000009 Filed on February 28, 2018

Income Statement

Concept	2017	2016 Q4	2016 Q3
Revenue	$286.6M	$72.90M	$68.36M
YoY Change	3.71%	5.17%	9.87%
Cost Of Revenue	$87.92M	$23.62M	$43.15M
YoY Change	-20.15%	21.59%	171.38%
Gross Profit	$198.7M	$49.28M	$25.20M
YoY Change	19.52%	-1.23%	-45.58%
Gross Profit Margin	69.33%	67.6%	36.87%
Selling, General & Admin	$161.5M	$34.70M	$36.31M
YoY Change	5.82%	-7.71%	2.84%
% of Gross Profit	81.27%	70.41%	144.09%
Research & Development	$57.29M	$17.10M	$9.754M
YoY Change	25.42%	29.55%	65.52%
% of Gross Profit	28.83%	34.7%	38.7%
Depreciation & Amortization	$13.83M	$3.260M	$3.300M
YoY Change	7.07%	4.49%	17.86%
% of Gross Profit	6.96%	6.62%	13.09%
Operating Expenses	$311.6M	$75.36M	$89.22M
YoY Change	1.03%	7.46%	56.24%
Operating Profit	-$24.94M	-$26.08M	-$20.87M
YoY Change	-22.13%	28.86%	-508.4%
Interest Expense	$18.05M	-$1.500M	$1.601M
YoY Change	155.59%	-11.76%	-15.96%
% of Operating Profit
Other Income/Expense, Net	-$17.53M	-$100.0K	-$1.263M
YoY Change	201.27%	0.0%	-27.5%
Pretax Income	-$42.47M	-$4.000M	-$22.13M
YoY Change	12.23%	53.85%	-757.2%
Income Tax	$140.0K	$0.00	$36.00K
% Of Pretax Income
Net Earnings	-$42.61M	-$3.973M	-$22.16M
YoY Change	12.28%	59.05%	-818.21%
Net Earnings / Revenue	-14.87%	-5.45%	-32.42%
Basic Earnings Per Share	-$1.07		-$0.59
Diluted Earnings Per Share	-$1.07	-$107.0K	-$0.59
COMMON SHARES
Basic Shares Outstanding	39.81M shares	37.40M shares	37.31M shares
Diluted Shares Outstanding	39.81M shares		37.31M shares

Balance Sheet

Concept	2017	2016 Q4	2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$311.3M	$172.6M	$161.1M
YoY Change	80.36%	8.55%	10.04%
Cash & Equivalents	$54.10M	$35.94M	$24.44M
Short-Term Investments	$257.2M	$136.7M	$136.7M
Other Short-Term Assets	$6.700M	$9.300M	$10.10M
YoY Change	-27.96%	52.46%	119.57%
Inventory	$41.40M	$31.28M	$37.48M
Prepaid Expenses
Receivables	$31.70M	$29.94M	$26.77M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$391.1M	$243.1M	$235.4M
YoY Change	60.88%	-3.76%	1.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$107.0M	$101.0M	$100.4M
YoY Change	5.94%	11.84%	16.29%
Goodwill		$46.74M	$44.67M
YoY Change		51.35%	54.63%
Intangibles
YoY Change
Long-Term Investments	$74.20M	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Assets	$800.0K	$624.0K	$651.0K
YoY Change	33.33%	53.69%	-74.91%
Total Long-Term Assets	$237.3M	$148.4M	$145.7M
YoY Change	59.91%	9.78%	7.23%
TOTAL ASSETS
Total Short-Term Assets	$391.1M	$243.1M	$235.4M
Total Long-Term Assets	$237.3M	$148.4M	$145.7M
Total Assets	$628.4M	$391.5M	$381.2M
YoY Change	60.51%	0.96%	3.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$14.70M	$7.511M	$7.287M
YoY Change	96.0%	-14.05%	-13.98%
Accrued Expenses	$39.10M	$36.67M	$31.08M
YoY Change	17.77%	3.65%	2.58%
Deferred Revenue
YoY Change
Short-Term Debt	$300.0K	$0.00	$107.6M
YoY Change		-100.0%	2.57%
Long-Term Debt Due		$118.5M
YoY Change		0.0%
Total Short-Term Liabilities	$56.20M	$44.84M	$146.8M
YoY Change	25.45%	-70.07%	0.98%
LONG-TERM LIABILITIES
Long-Term Debt	$276.2M	$108.7M	$0.00
YoY Change	154.09%
Other Long-Term Liabilities	$16.50M	$18.91M	$12.56M
YoY Change	-12.7%	64.86%	105.01%
Total Long-Term Liabilities	$292.7M	$18.91M	$12.56M
YoY Change	129.39%	64.86%	105.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$56.20M	$44.84M	$146.8M
Total Long-Term Liabilities	$292.7M	$18.91M	$12.56M
Total Liabilities	$348.9M	$172.5M	$167.0M
YoY Change	102.26%	1.86%	4.39%
SHAREHOLDERS EQUITY
Retained Earnings		-$346.2M	-$342.3M
YoY Change		12.31%	11.93%
Common Stock		$37.00K	$37.00K
YoY Change		0.0%	0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares		0.000 shares	0.000 shares
Shareholders Equity	$279.5M	$219.0M	$214.1M
YoY Change
Total Liabilities & Shareholders Equity	$628.4M	$391.5M	$381.2M
YoY Change	60.51%	0.96%	3.3%

Cashflow Statement

Concept	2017	2016 Q4	2016 Q3
OPERATING ACTIVITIES
Net Income	-$42.61M	-$3.973M	-$22.16M
YoY Change	12.28%	59.05%	-818.21%
Depreciation, Depletion And Amortization	$13.83M	$3.260M	$3.300M
YoY Change	7.07%	4.49%	17.86%
Cash From Operating Activities	$17.79M	$17.35M	$11.68M
YoY Change	-46.83%	8.03%	314.18%
INVESTING ACTIVITIES
Capital Expenditures	$19.27M	-$4.880M	-$3.910M
YoY Change	-22.03%	-40.12%	-59.31%
Acquisitions	$0.00
YoY Change
Other Investing Activities	-$204.5M	-$2.040M	-$9.410M
YoY Change	451.96%	-112.45%	-440.94%
Cash From Investing Activities	-$223.8M	-$6.910M	-$13.32M
YoY Change	262.37%	-183.96%	94.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$224.2M	1.070M	770.0K
YoY Change	2987.63%	-50.69%	-57.92%
NET CHANGE
Cash From Operating Activities	$17.79M	17.35M	11.68M
Cash From Investing Activities	-$223.8M	-6.910M	-13.32M
Cash From Financing Activities	$224.2M	1.070M	770.0K
Net Change In Cash	$18.18M	11.51M	-870.0K
YoY Change	-186.42%	-56.5%	-60.27%
FREE CASH FLOW
Cash From Operating Activities	$17.79M	$17.35M	$11.68M
Capital Expenditures	$19.27M	-$4.880M	-$3.910M
Free Cash Flow	-$1.481M	$22.23M	$15.59M
YoY Change	-116.94%	-8.18%	25.42%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017	dei	Amendment Flag AmendmentFlag	false
CY2017	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2017	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2017	dei	Document Period End Date DocumentPeriodEndDate	2017-12-31
CY2017	dei	Document Type DocumentType	10-K
CY2017	dei	Entity Central Index Key EntityCentralIndexKey	0001396814
CY2018Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	40711707	shares
CY2017	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2017	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q2	dei	Entity Public Float EntityPublicFloat	1900000000	USD
CY2017	dei	Entity Registrant Name EntityRegistrantName	Pacira Pharmaceuticals, Inc.
CY2017	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2017	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2016Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	1605000	USD
CY2017Q4	pcrx	Accrued End Of Term Fee Current AccruedEndOfTermFeeCurrent	2053000	USD
CY2016Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	16538000	USD
CY2017Q4	pcrx	Accrued Operating Expenses Current AccruedOperatingExpensesCurrent	20646000	USD
CY2015	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	481000	USD
CY2016	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	479000	USD
CY2017	pcrx	Amortization Of Other Assets And Unfavorable Lease Obligation AmortizationOfOtherAssetsAndUnfavorableLeaseObligation	1248000	USD
CY2017	pcrx	Beginning Period Prior To Product Expiration Allowed For Returning Product BeginningPeriodPriorToProductExpirationAllowedForReturningProduct	P6M
CY2015	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	1426000	USD
CY2016	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	3426000	USD
CY2017	pcrx	Collaborative Licensing And Development Revenue CollaborativeLicensingAndDevelopmentRevenue	387000	USD
CY2015	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	852000	USD
CY2016	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	785000	USD
CY2017	pcrx	Compensationexpensefromemployeestockpurchaseplan Compensationexpensefromemployeestockpurchaseplan	680000	USD
CY2015	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	27262000	USD
CY2016	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	24505000	USD
CY2017	pcrx	Compensationexpensefromstockoptionsemployees Compensationexpensefromstockoptionsemployees	24056000	USD
CY2015	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	2367000	USD
CY2016	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	841000	USD
CY2017	pcrx	Compensationexpensefromstockoptionsnonemployeeawards Compensationexpensefromstockoptionsnonemployeeawards	167000	USD
CY2012Q2	pcrx	Contingent Payment Obligation Established For Sale Of Product In Connection With Acquisition ContingentPaymentObligationEstablishedForSaleOfProductInConnectionWithAcquisition	2000000	USD
CY2017Q4	pcrx	Contract Termination Fee ContractTerminationFee	7100000	USD
CY2017Q4	pcrx	Contract Termination Fee Current Portion ContractTerminationFeeCurrentPortion	2400000	USD
CY2015	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
CY2016	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	0	USD
CY2017	pcrx	Conversionofprincipalandequitycomponentofconvertibleseniornotes Conversionofprincipalandequitycomponentofconvertibleseniornotes	285000	USD
CY2015	pcrx	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	3929000	USD
CY2016	pcrx	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	0	USD
CY2017	pcrx	Debt Conversion Converted Instrument Shares Issued Value DebtConversionConvertedInstrumentSharesIssuedValue	120960000	USD
	pcrx	Debt Instrument Conversion Obligation Numberof Trading Days Priorto Dateonwhich Entity Provides Noticeof Redemption DebtInstrumentConversionObligationNumberofTradingDaysPriortoDateonwhichEntityProvidesNoticeofRedemption	P30D
CY2017	pcrx	Debt Instrument Convertible Conversion Premium Shares DebtInstrumentConvertibleConversionPremiumShares	10000	shares
CY2017Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	120230000	USD
CY2016Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	21890000	USD
CY2017Q4	pcrx	Debt Instrument Convertible Conversion Value DebtInstrumentConvertibleConversionValue	300000	USD
CY2016Q4	pcrx	Deferred Tax Assets Gross Netof Deferred Tax Liabilities Before Valuation Allowance DeferredTaxAssetsGrossNetofDeferredTaxLiabilitiesBeforeValuationAllowance	148753000	USD
CY2017Q4	pcrx	Deferred Tax Assets Stock Based Compensation DeferredTaxAssetsStockBasedCompensation	16925000	USD
CY2017	pcrx	Discontinued Operations Assetsremovedfrom Service DiscontinuedOperationsAssetsremovedfromService	2470000	USD
CY2017	pcrx	Discontinued Operations Fixed Assetand Inventory Writedown DiscontinuedOperationsFixedAssetandInventoryWritedown	2470000	USD
CY2017	pcrx	Discontinued Operations Payments For Lease Costs DiscontinuedOperationsPaymentsForLeaseCosts	744000	USD
CY2017	pcrx	Discontinued Operations Remaining Lease Costs DiscontinuedOperationsRemainingLeaseCosts	2018000	USD
CY2016Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	0	USD
CY2017Q4	pcrx	Discontinued Operations Residual Lease Costs DiscontinuedOperationsResidualLeaseCosts	1274000	USD
CY2015	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0.0000
CY2016	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0.0000
CY2017	pcrx	Effective Income Tax Rate Reconciliation Convertible Senior Notes Refinancing EffectiveIncomeTaxRateReconciliationConvertibleSeniorNotesRefinancing	0.0655
CY2015	pcrx	Effective Income Tax Rate Reconciliation Effect Of New Accounting Pronouncements EffectiveIncomeTaxRateReconciliationEffectOfNewAccountingPronouncements	0.0000
CY2016	pcrx	Effective Income Tax Rate Reconciliation Effect Of New Accounting Pronouncements EffectiveIncomeTaxRateReconciliationEffectOfNewAccountingPronouncements	0.0000
CY2017	pcrx	Effective Income Tax Rate Reconciliation Effect Of New Accounting Pronouncements EffectiveIncomeTaxRateReconciliationEffectOfNewAccountingPronouncements	0.6889
CY2015	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	0.1203
CY2016	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0081
CY2017	pcrx	Effective Income Tax Rate Reconciliation Foreign EffectiveIncomeTaxRateReconciliationForeign	-0.0128
CY2015	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	-0.3757
CY2016	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0.0575
CY2017	pcrx	Effective Income Tax Rate Reconciliation Interest Expense Percent EffectiveIncomeTaxRateReconciliationInterestExpensePercent	0.0290
CY2017Q1	pcrx	Effective Income Tax Rate Reconciliation Sharebased Compensation Excess Tax EffectiveIncomeTaxRateReconciliationSharebasedCompensationExcessTax	29300000	USD
CY2015	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	0.0000
CY2016	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	-0.0465
CY2017	pcrx	Effectofstateblendedtaxratechanges Effectofstateblendedtaxratechanges	-1.3088
CY2017Q4	pcrx	Employee Stock Purchase Plan Espp Sharesin Espp EmployeeStockPurchasePlanESPPSharesinESPP	500000	shares
CY2017	pcrx	Employee Stock Purchase Plan Numberof Shares Authorized EmployeeStockPurchasePlanNumberofSharesAuthorized	500000	shares
CY2017	pcrx	Employee Stock Purchase Plan Numberof Shares Available For Purchase EmployeeStockPurchasePlanNumberofSharesAvailableForPurchase	339853	shares
CY2017Q4	pcrx	Employee Stock Purchase Planfairvalue EmployeeStockPurchasePlanfairvalue	0.85
CY2015	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2016	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	0	USD
CY2017	pcrx	Fair Market Valueof Common Stock Issuedfor Convertible Senior Notes Premium FairMarketValueofCommonStockIssuedforConvertibleSeniorNotesPremium	126328000	USD
CY2016Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	33700000	USD
CY2017Q4	pcrx	Foreign Property Plantand Equipment Net ForeignPropertyPlantandEquipmentNet	59800000	USD
CY2016	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	7857000	USD
CY2017	pcrx	Goodwill Recordedfor Earn Out Payments GoodwillRecordedforEarnOutPayments	8460000	USD
CY2016	pcrx	Goodwill Recordedon Milestone Payments GoodwillRecordedonMilestonePayments	8000000	USD
CY2015	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	2120000	USD
CY2016	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-37844000	USD
CY2017	pcrx	Income Lossfrom Continuing Operationsbefore Income Taxes Total IncomeLossfromContinuingOperationsbeforeIncomeTaxesTotal	-42471000	USD
CY2015	pcrx	Income Tax Provision IncomeTaxProvision	300000	USD
CY2016	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2017	pcrx	Income Tax Provision IncomeTaxProvision	100000	USD
CY2015	pcrx	Increase Decrease In Capital Expenditures Incurred And Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredAndNotYetPaid	1393000	USD
CY2016	pcrx	Increase Decrease In Capital Expenditures Incurred And Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredAndNotYetPaid	-789000	USD
CY2017	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	0	USD
CY2015	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	3000	shares
CY2017	pcrx	Increase Decrease In Capital Expenditures Incurred And Not Yet Paid IncreaseDecreaseInCapitalExpendituresIncurredAndNotYetPaid	2189000	USD
CY2015	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	276000	USD
CY2016	pcrx	Increase Decrease In Royalty Interest Obligation IncreaseDecreaseInRoyaltyInterestObligation	0	USD
CY2016	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
CY2017	pcrx	Incremental Common Shares Attributableto Dilutive Effectof Restricted Stock Units IncrementalCommonSharesAttributabletoDilutiveEffectofRestrictedStockUnits	0	shares
CY2017Q4	pcrx	Investments Contingent Purchase Obligation InvestmentsContingentPurchaseObligation	900000	USD
CY2017Q4	pcrx	Maximum Fair Market Value Purchaseof Espp Shares MaximumFairMarketValuePurchaseofESPPShares	25000	USD
CY2017	pcrx	Minimum Cumulative Percentage Of Change In Ownership As Condition To Offset Taxable Income Or Tax MinimumCumulativePercentageOfChangeInOwnershipAsConditionToOffsetTaxableIncomeOrTax	0.5
CY2017Q4	pcrx	Non Us Net Operating Loss NonUSNetOperatingLoss	5900000	USD
CY2016	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2017	pcrx	Number Of Major Customers NumberOfMajorCustomers	3	customer
CY2012Q2	pcrx	Payment Obligation Arising Due To First Commercial Sale Of Product In Connection With Acquisition PaymentObligationArisingDueToFirstCommercialSaleOfProductInConnectionWithAcquisition	10000000	USD
CY2015	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	7119000	USD
CY2016	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	15857000	USD
CY2017	pcrx	Payment Of Contingent Consideration PaymentOfContingentConsideration	8460000	USD
CY2017	pcrx	Period After Product Expiration Upto Which Product Is Allowed To Be Returned PeriodAfterProductExpirationUptoWhichProductIsAllowedToBeReturned	P12M
CY2015	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	2093000	USD
CY2016	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1495000	USD
CY2017	pcrx	Proceeds From Shares Issued Under Employee Stock Purchase Plan ProceedsFromSharesIssuedUnderEmployeeStockPurchasePlan	1862000	USD
CY2016Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	3473000	USD
CY2017Q4	pcrx	Product Returns Rebatesand Other Fees ProductReturnsRebatesandOtherFees	1972000	USD
	pcrx	Settlement Period Convertible Debt Conversion Request SettlementPeriodConvertibleDebtConversionRequest	P40D
CY2017Q4	pcrx	Sharebased Compensationarrangementby Sharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue SharebasedCompensationarrangementbySharebasedpaymentawardequityinstrumentsothersthanoptionsvestedandexpectedtovestweightedaveragegrantdatefairvalue	47.32
CY2017Q4	pcrx	Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue Sharebasedcompensationarrangementbysharebasedpaymentawardequityinstrumentsotherthanoptionsvestedandexpectedtovestaggregateintrinsicvalue	22804000	USD
CY2017	pcrx	Tax Cutsand Jobs Actof2017 Changein Tax Rate Income Tax Expense Benefit TaxCutsandJobsActof2017ChangeinTaxRateIncomeTaxExpenseBenefit	55700000	USD
CY2017	pcrx	Total Changein Discontinued Operations Balance TotalChangeinDiscontinuedOperationsBalance	2470000	USD
CY2017Q4	pcrx	Total Goodwill Recordedfor Earn Out Payments TotalGoodwillRecordedforEarnOutPayments	31200000	USD
CY2015	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.35
CY2016	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.35
CY2017	pcrx	United States Statutory Tax Rate UnitedStatesStatutoryTaxRate	0.35
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	7511000	USD
CY2017Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14658000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	29937000	USD
CY2017Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31658000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	36666000	USD
CY2017Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	41057000	USD
CY2016Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	3822000	USD
CY2017Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	4091000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	37510000	USD
CY2017Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	49210000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-30000	USD
CY2017Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-454000	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	565207000	USD
CY2017Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	669032000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-4100000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Equity Component Of Convertible Debt AdjustmentsToAdditionalPaidInCapitalEquityComponentOfConvertibleDebt	-2000	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	33368000	USD
CY2016	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31248000	USD
CY2017	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	31601000	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	33368000	USD
CY2016	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31248000	USD
CY2017	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	31601000	USD
CY2015	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4102000	USD
CY2016	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	4088000	USD
CY2017	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10423000	USD
CY2015	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	300000	USD
CY2016	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	100000	USD
CY2017	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0	USD
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1998000	shares
CY2016	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6816000	shares
CY2017	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	6060000	shares
CY2016Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	500000	USD
CY2017Q4	us-gaap	Asset Retirement Obligation AssetRetirementObligation	1500000	USD
CY2017	us-gaap	Asset Retirement Obligation Accretion Expense AssetRetirementObligationAccretionExpense	100000	USD
CY2016Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	0	USD
CY2017Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	236000	USD
CY2017	us-gaap	Asset Retirement Obligation Liabilities Incurred AssetRetirementObligationLiabilitiesIncurred	400000	USD
CY2017	us-gaap	Asset Retirement Obligation Liabilities Settled AssetRetirementObligationLiabilitiesSettled	420000	USD
CY2016Q4	us-gaap	Assets Assets	391466000	USD
CY2017Q4	us-gaap	Assets Assets	628371000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	243089000	USD
CY2017Q4	us-gaap	Assets Current AssetsCurrent	391110000	USD
CY2016Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	136683000	USD
CY2017Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	317722000	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	19000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2016Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	49000	USD
CY2017Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	454000	USD
CY2017Q3	us-gaap	Business Combination Contingent Consideration Arrangements Range Of Outcomes Value High BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh	10000000	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	37520000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	56984000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	35944000	USD
CY2017Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	54126000	USD
CY2012Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	162885	shares
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2017Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	250000000	shares
CY2016Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	37480952	shares
CY2017Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	40668877	shares
CY2016Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	37480952	shares
CY2017Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	40668877	shares
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	37000	USD
CY2017Q4	us-gaap	Common Stock Value CommonStockValue	41000	USD
CY2015	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	1884000	USD
CY2016	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-37927000	USD
CY2017	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-43035000	USD
CY2016Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	0	USD
CY2017Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	324000	USD
CY2016Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	108738000	USD
CY2017Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	276173000	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	71837000	USD
CY2016Q1	us-gaap	Cost Of Revenue CostOfRevenue	20278000	USD
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	23053000	USD
CY2016Q3	us-gaap	Cost Of Revenue CostOfRevenue	43152000	USD
CY2016Q4	us-gaap	Cost Of Revenue CostOfRevenue	23621000	USD
CY2016	us-gaap	Cost Of Revenue CostOfRevenue	110104000	USD
CY2017Q1	us-gaap	Cost Of Revenue CostOfRevenue	24581000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	23811000	USD
CY2017Q3	us-gaap	Cost Of Revenue CostOfRevenue	18228000	USD
CY2017Q4	us-gaap	Cost Of Revenue CostOfRevenue	21295000	USD
CY2017	us-gaap	Cost Of Revenue CostOfRevenue	87915000	USD
CY2017	us-gaap	Costs Incurred Asset Retirement Obligation Incurred CostsIncurredAssetRetirementObligationIncurred	656000	USD
CY2017Q1	us-gaap	Cumulative Effect On Retained Earnings Net Of Tax1 CumulativeEffectOnRetainedEarningsNetOfTax1	300000	USD
CY2015	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	92000	USD
CY2016	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	11000	USD
CY2017	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	USD
CY2015	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	172000	USD
CY2016	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	94000	USD
CY2017	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	140000	USD
CY2017Q1	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	2500000	shares
CY2017Q2	us-gaap	Debt Conversion Converted Instrument Shares Issued1 DebtConversionConvertedInstrumentSharesIssued1	10000	shares
	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.3
	us-gaap	Debt Instrument Convertible Threshold Trading Days DebtInstrumentConvertibleThresholdTradingDays	20	D
CY2016Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	8600000	USD
CY2017Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	6800000	USD
CY2016Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	595000	USD
CY2017Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	102000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	3023000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	1841000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	151939000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	134908000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	9811000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	552000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2017Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	0	USD
CY2016Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	96163000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	95067000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	52000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	139000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2604000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	2593000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	13724000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	15048000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	4672000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2743000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	148753000	USD
CY2017Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	120230000	USD
CY2016Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	3186000	USD
CY2017Q4	us-gaap	Deferred Tax Liabilities Financing Arrangements DeferredTaxLiabilitiesFinancingArrangements	14678000	USD
CY2015	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1700000	USD
CY2016	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1500000	USD
CY2017	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1300000	USD
CY2015	us-gaap	Depreciation Depreciation	11200000	USD
CY2016	us-gaap	Depreciation Depreciation	12800000	USD
CY2017	us-gaap	Depreciation Depreciation	13800000	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	11475000	USD
CY2016	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12919000	USD
CY2017	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13833000	USD
CY2016Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	0	USD
CY2017Q4	us-gaap	Discontinued Operation Amounts Of Material Contingent Liabilities Remaining DiscontinuedOperationAmountsOfMaterialContingentLiabilitiesRemaining	1510000	USD
CY2015	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2016	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	0	USD
CY2017	us-gaap	Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax	-4868000	USD
CY2017	us-gaap	Discontinued Operation Tax Effect Of Income Loss From Disposal Of Discontinued Operation DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation	5400000	USD
CY2017	us-gaap	Disposal Group Including Discontinued Operation Operating Expense DisposalGroupIncludingDiscontinuedOperationOperatingExpense	1467000	USD
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2016	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.02
CY2017	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.07
CY2016Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.10
CY2016Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.21
CY2016Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.59
CY2016Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.11
CY2017Q1	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.52
CY2017Q2	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.49
CY2017Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.19
CY2017Q4	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	0.11
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2016	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.02
CY2017	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.07
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.1245
CY2016	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0028
CY2017	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0033
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2016	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2017	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.1032
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.4396
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.0458
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0726
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0054
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0121
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.1533
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	-0.0204
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.0790
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0071
CY2016	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0220
CY2017	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.0226
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.3063
CY2016	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0877
CY2017	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.0496
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	11228000	USD
CY2017Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	12295000	USD
CY2015	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-6000	USD
CY2016	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-389000	USD
CY2017	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2133000	USD
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3700000	USD
CY2015	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-52000	USD
CY2017	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-3732000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	30880000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	46737000	USD
CY2017Q4	us-gaap	Goodwill Goodwill	55197000	USD
CY2012Q2	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	8000000	USD
CY2017Q4	us-gaap	Incentive From Lessor IncentiveFromLessor	5600000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	3760000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-36339000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-39898000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2120000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-37844000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-42471000	USD
CY2015	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1640000	USD
CY2016	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-1505000	USD
CY2017	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-2573000	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	264000	USD
CY2016	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	105000	USD
CY2017	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	140000	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	195000	USD
CY2016	us-gaap	Income Taxes Paid IncomeTaxesPaid	247000	USD
CY2017	us-gaap	Income Taxes Paid IncomeTaxesPaid	129000	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	8966000	USD
CY2016	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	710000	USD
CY2017	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	9359000	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3489000	USD
CY2016	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4082000	USD
CY2017	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1721000	USD
CY2017	us-gaap	Increase Decrease In Asset Retirement Obligations IncreaseDecreaseInAssetRetirementObligations	500000	USD
CY2015	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32382000	USD
CY2016	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-30367000	USD
CY2017	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10133000	USD
CY2015	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	4360000	USD
CY2016	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1339000	USD
CY2017	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-3555000	USD
CY2015	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2007000	USD
CY2016	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3377000	USD
CY2017	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-3476000	USD
CY2015	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-1509000	USD
CY2016	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2017	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	0	USD
CY2015	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	6000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	3113000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	1000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Equity Unit Purchase Agreements IncrementalCommonSharesAttributableToEquityUnitPurchaseAgreements	0	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1638000	shares
CY2016	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2017	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2015	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	800000	USD
CY2016	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1500000	USD
CY2017	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	1100000	USD
CY2015	us-gaap	Interest Expense InterestExpense	7725000	USD
CY2016	us-gaap	Interest Expense InterestExpense	7061000	USD
CY2017	us-gaap	Interest Expense InterestExpense	18047000	USD
CY2015	us-gaap	Interest Paid InterestPaid	4224000	USD
CY2016	us-gaap	Interest Paid InterestPaid	3852000	USD
CY2017	us-gaap	Interest Paid InterestPaid	6896000	USD
CY2016Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	7915000	USD
CY2017Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	16540000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	31278000	USD
CY2017Q4	us-gaap	Inventory Net InventoryNet	41411000	USD
CY2016Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	11742000	USD
CY2017Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	16500000	USD
CY2016Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	11621000	USD
CY2017Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8371000	USD
CY2016	us-gaap	Inventory Write Down InventoryWriteDown	20700000	USD
CY2015	us-gaap	Investment Income Interest InvestmentIncomeInterest	678000	USD
CY2016	us-gaap	Investment Income Interest InvestmentIncomeInterest	1323000	USD
CY2017	us-gaap	Investment Income Interest InvestmentIncomeInterest	4078000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	172490000	USD
CY2017Q4	us-gaap	Liabilities Liabilities	348888000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	391466000	USD
CY2017Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	628371000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	44838000	USD
CY2017Q4	us-gaap	Liabilities Current LiabilitiesCurrent	56217000	USD
CY2016Q4	us-gaap	Long Term Investments LongTermInvestments	0	USD
CY2017Q4	us-gaap	Long Term Investments LongTermInvestments	60047000	USD
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	19464000	USD
CY2016	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-21040000	USD
CY2017	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	18182000	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	10699000	USD
CY2016	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	7261000	USD
CY2017	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	224162000	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-19256000	USD
CY2016	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-61754000	USD
CY2017	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-223765000	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	28021000	USD
CY2016	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	33453000	USD
CY2017	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	17785000	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	1856000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	-3854000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	-7958000	USD
CY2016Q3	us-gaap	Net Income Loss NetIncomeLoss	-22164000	USD
CY2016Q4	us-gaap	Net Income Loss NetIncomeLoss	-3973000	USD
CY2016	us-gaap	Net Income Loss NetIncomeLoss	-37949000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	-19866000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	-19743000	USD
CY2017Q3	us-gaap	Net Income Loss NetIncomeLoss	-7597000	USD
CY2017Q4	us-gaap	Net Income Loss NetIncomeLoss	4595000	USD
CY2017	us-gaap	Net Income Loss NetIncomeLoss	-42611000	USD
CY2015	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-7335000	USD
CY2016	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5820000	USD
CY2017	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17534000	USD
CY2017	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2015	us-gaap	Operating Expenses OperatingExpenses	239542000	USD
CY2016Q1	us-gaap	Operating Expenses OperatingExpenses	67728000	USD
CY2016Q2	us-gaap	Operating Expenses OperatingExpenses	76084000	USD
CY2016Q3	us-gaap	Operating Expenses OperatingExpenses	89220000	USD
CY2016Q4	us-gaap	Operating Expenses OperatingExpenses	75363000	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	9455000	USD
CY2016	us-gaap	Operating Income Loss OperatingIncomeLoss	-32024000	USD
CY2017	us-gaap	Operating Income Loss OperatingIncomeLoss	-24937000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	53733000	USD
CY2016	us-gaap	Operating Expenses OperatingExpenses	308395000	USD
CY2017Q1	us-gaap	Operating Expenses OperatingExpenses	83333000	USD
CY2017Q2	us-gaap	Operating Expenses OperatingExpenses	86714000	USD
CY2017Q3	us-gaap	Operating Expenses OperatingExpenses	70907000	USD
CY2017Q4	us-gaap	Operating Expenses OperatingExpenses	70613000	USD
CY2017	us-gaap	Operating Expenses OperatingExpenses	311567000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	7886000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	5366000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	5245000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	7570000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	8089000	USD
CY2017Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	19577000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	5700000	USD
CY2016	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	6000000	USD
CY2017	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	7500000	USD
CY2016Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	624000	USD
CY2017Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	825000	USD
CY2015	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	28000	USD
CY2016	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	22000	USD
CY2017	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-424000	USD
CY2015	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	28000	USD
CY2016	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	22000	USD
CY2017	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax	-424000	USD
CY2016Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	18914000	USD
CY2017Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	16498000	USD
CY2015	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-165000	USD
CY2016	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-82000	USD
CY2017	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	167000	USD
CY2017	us-gaap	Payments For Postemployment Benefits PaymentsForPostemploymentBenefits	303000	USD
CY2015	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2016	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
CY2017	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11000000	USD
CY2015	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	USD
CY2016	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	0	USD
CY2017	us-gaap	Payments To Acquire Businesses And Interest In Affiliates PaymentsToAcquireBusinessesAndInterestInAffiliates	15000000	USD
CY2017Q4	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15000000	USD
CY2015	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	189082000	USD
CY2016	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	192815000	USD
CY2017	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	502752000	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	40295000	USD
CY2016	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	24709000	USD
CY2017	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	19266000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2017Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2017Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	9277000	USD
CY2016	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5770000	USD
CY2017	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6778000	USD
CY2017Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6694000	USD
CY2015	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2016	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2017	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	345000000	USD
CY2015	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	217240000	USD
CY2016	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	171627000	USD
CY2017	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	321713000	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	10073000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	138526000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	156256000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	101016000	USD
CY2017Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	107046000	USD
CY2017Q4	us-gaap	Purchase Obligation PurchaseObligation	300000	USD
CY2015	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	1467000	USD
CY2016	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	4000	USD
CY2017	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	118193000	USD
CY2015	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	28662000	USD
CY2016	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	45678000	USD
CY2017	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	57290000	USD
CY2015	us-gaap	Restricted Stock Expense RestrictedStockExpense	2887000	USD
CY2016	us-gaap	Restricted Stock Expense RestrictedStockExpense	5117000	USD
CY2017	us-gaap	Restricted Stock Expense RestrictedStockExpense	6698000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-346238000	USD
CY2017Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-389136000	USD
CY2015	us-gaap	Revenues Revenues	248997000	USD
CY2016Q1	us-gaap	Revenues Revenues	65474000	USD
CY2016Q2	us-gaap	Revenues Revenues	69640000	USD
CY2016Q3	us-gaap	Revenues Revenues	68355000	USD
CY2016Q4	us-gaap	Revenues Revenues	72902000	USD
CY2016	us-gaap	Revenues Revenues	276371000	USD
CY2017Q1	us-gaap	Revenues Revenues	69283000	USD
CY2017Q2	us-gaap	Revenues Revenues	70934000	USD
CY2017Q3	us-gaap	Revenues Revenues	67335000	USD
CY2017Q4	us-gaap	Revenues Revenues	79078000	USD
CY2017	us-gaap	Revenues Revenues	286630000	USD
CY2015	us-gaap	Royalty Expense RoyaltyExpense	71000	USD
CY2016	us-gaap	Royalty Expense RoyaltyExpense	0	USD
CY2017	us-gaap	Royalty Expense RoyaltyExpense	0	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	3084000	USD
CY2016	us-gaap	Royalty Revenue RoyaltyRevenue	2872000	USD
CY2017	us-gaap	Royalty Revenue RoyaltyRevenue	1901000	USD
CY2015	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	244487000	USD
CY2016	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	270073000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	12129537	shares
CY2017	us-gaap	Sales Revenue Goods Net SalesRevenueGoodsNet	284342000	USD
CY2015	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	139043000	USD
CY2016	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	152613000	USD
CY2017	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	161494000	USD
CY2017	us-gaap	Severance Costs1 SeveranceCosts1	303000	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	33368000	USD
CY2016	us-gaap	Share Based Compensation ShareBasedCompensation	31248000	USD
CY2017	us-gaap	Share Based Compensation ShareBasedCompensation	31601000	USD
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	4000000	shares
CY2017	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	16368000	USD
CY2017Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3016477	shares
CY2017	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod	9113060	shares
CY2017Q4	us-gaap	Share Price SharePrice	45.65
CY2016Q4	us-gaap	Short Term Investments ShortTermInvestments	136653000	USD
CY2017Q4	us-gaap	Short Term Investments ShortTermInvestments	257221000	USD
CY2017	us-gaap	Stock Issued During Period Shares Employee Stock Purchase Plans StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans	160147	shares
CY2015	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	3929000	USD
CY2017	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	120960000	USD
CY2015	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2093000	USD
CY2016	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1495000	USD
CY2017	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1862000	USD
CY2016	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2017	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	10073000	USD
CY2016	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5770000	USD
CY2017	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	6778000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	171145000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	218392000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	218976000	USD
CY2017Q4	us-gaap	Stockholders Equity StockholdersEquity	279483000	USD
CY2016Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	0	USD
CY2017Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14000000	USD
CY2017Q4	us-gaap	Summary Of Investments Other Than Investments In Related Parties Carrying Amount SummaryOfInvestmentsOtherThanInvestmentsInRelatedPartiesCarryingAmount	14146000	USD
CY2016Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2017Q4	us-gaap	Supplemental Unemployment Benefits Severance Benefits SupplementalUnemploymentBenefitsSeveranceBenefits	0	USD
CY2016Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	66000	USD
CY2017Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	76000	USD
CY2016Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2017Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	0	shares
CY2015Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2016Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0	USD
CY2017Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2500000	USD
CY2017	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1400000	USD
CY2016	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	1100000	USD
CY2015	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	800000	USD
CY2016	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	16600000	USD
CY2017	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-28500000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	10746000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	12871000	USD
CY2017	us-gaap	Valuation Allowances And Reserves Adjustments ValuationAllowancesAndReservesAdjustments	15581000	USD
CY2014Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3043000	USD
CY2015Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3900000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3800000	USD
CY2017Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	3013000	USD
CY2015	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	9889000	USD
CY2016	us-gaap	Valuation Allowances And Reserves Deductions ValuationAllowancesAndReservesDeductions	12971000	USD
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	41301000	shares
CY2016	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37236000	shares
CY2017	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	39806000	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	36540000	shares
CY2016	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	37236000	shares
CY2017	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	39806000	shares
CY2017	us-gaap	Description Of New Accounting Pronouncements Not Yet Adopted DescriptionOfNewAccountingPronouncementsNotYetAdopted	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">RECENT ACCOUNTING PRONOUNCEMENTS</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Recently Adopted</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In March 2016, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2016-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Compensation—Stock Compensation (Topic 718): Improvements to Employee Share-Based Payment Accounting</font><font style="font-family:inherit;font-size:10pt;">. This update includes multiple provisions intended to simplify various aspects of accounting for share-based payment transactions including accounting for excess tax benefits and tax deficiencies, classification of excess tax benefits and tax deficiencies in the statement of cash flows and accounting for award forfeitures. The update also removes the requirement to delay recognition of an excess tax benefit until it reduces current taxes payable, instead, it is required to be recognized at the time of settlement, subject to normal valuation allowance considerations. This update became effective for the Company beginning January 1, 2017. The Company elected an accounting policy change to record forfeitures as they occur rather than estimating forfeitures during each period and recorded a charge of </font><font style="font-family:inherit;font-size:10pt;">$0.3 million</font><font style="font-family:inherit;font-size:10pt;"> to retained earnings as of January 1, 2017 related to the reversal of cumulative forfeiture estimates. The adoption of this standard also resulted in the recognition of </font><font style="font-family:inherit;font-size:10pt;">$29.3 million</font><font style="font-family:inherit;font-size:10pt;"> of previously unrecognized excess tax benefits in deferred tax assets, fully offset by a valuation allowance. The changes have been applied prospectively in accordance with the update, and prior periods have not been adjusted. All tax-related cash flows resulting from stock-based compensation, including the excess tax benefits related to the settlement of stock-based awards, will be classified as cash flows from operating activities in the Company’s consolidated statements of cash flows.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In July 2015, the FASB issued ASU 2015-11, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Inventory (Topic 330): Simplifying the Measurement of Inventory</font><font style="font-family:inherit;font-size:10pt;">. The standard requires entities to measure most inventory “at the lower of cost and net realizable value”, thereby simplifying the current guidance under which an entity must measure inventory at the lower of cost or market (market in this context is defined as one of three different measures, one of which is net realizable value). Net realizable value is the estimated selling price in the ordinary course of business, less reasonably predictable costs of completion, disposal and transportation. The standard became effective for the Company prospectively beginning January 1, 2017. The adoption of ASU 2015-11 did not have a material impact on the Company’s consolidated financial statements.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Not Adopted as of </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">December 31, 2017</font></div><div style="line-height:120%;padding-top:0px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In May 2014, the FASB issued ASU 2014-09, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Revenue from Contracts with Customers</font><font style="font-family:inherit;font-size:10pt;">, and has subsequently issued a number of amendments to this update. The new standard, as amended, provides a single comprehensive model to be used in accounting for revenue arising from contracts with customers and supersedes current revenue recognition guidance. The standard’s stated core principle is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve this core principle, ASU 2014-09 provides a five-step model that includes (1) identifying the contract with a customer, (2) identifying the performance obligations in the contract, (3) determining the transaction price, (4) allocating the transaction price to the performance obligations and (5) recognizing revenue when, or as, an entity satisfies a performance obligation. In addition, the standard requires disclosure of the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The new standard will become effective for the Company beginning January 1, 2018 and permits two methods of adoption: the full retrospective method, which requires the standard to be applied to each prior period presented, or the modified retrospective method, which requires the cumulative effect of adoption to be recognized as an adjustment to opening retained earnings in the period of adoption. The Company will adopt this standard using the modified retrospective method.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The Company has completed an analysis of existing contracts with its customers and assessed the differences in accounting for such contracts under ASU 2014-09 compared with the current revenue accounting standards. Based on its review of its current customer contracts, the implementation of ASU 2014-09 will not have a material quantitative impact on the Company’s consolidated financial statements, as the timing of revenue recognition for EXPAREL product sales is not expected to significantly change. The Company will recognize existing collaborative licensing, milestone and royalty revenue earlier, subject to the variable consideration constraints, than it would have under the current standard, however, such changes are not expected to be material to the Company’s consolidated financial statements. Adoption of the new standard will result in additional revenue-related disclosures in the footnotes to the Company’s consolidated financial statements.</font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In January 2016, the FASB issued ASU 2016-01, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments—Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities</font><font style="font-family:inherit;font-size:10pt;">. ASU 2016-01 changes accounting for equity investments and presentation and disclosure requirements for financial instruments. ASU 2016-01 does not apply to equity investments in consolidated subsidiaries or those accounted for under the equity method of accounting. Equity investments with readily determinable fair values will be measured at fair value with changes in fair value recognized in net income (loss). Entities have the option to measure equity investments without readily determinable fair values either at fair value or at cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or a similar investment of the same issuer. The standard also simplifies the impairment assessment of equity investments without readily determinable fair values by requiring a qualitative assessment to identify impairment. When a qualitative assessment indicates that impairment exists, an entity is required to measure the investment at fair value. ASU 2016-01 will become effective for the Company beginning January 1, 2018. The Company has elected to measure equity investments without readily determinable fair values at cost adjusted for changes in observable prices. The guidance related to equity investments without readily determinable fair values will be applied prospectively to equity investments that exist as of the date of adoption. The adoption of ASU 2016-01 may increase volatility in the Company’s net income as changes in observable prices of equity investments without readily determinable fair values will be recorded in net income (loss). The Company does not expect the implementation of this standard to have a material impact on its consolidated financial statements and related disclosures.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In February 2016, the FASB issued ASU 2016-02, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Leases (Topic 842)</font><font style="font-family:inherit;font-size:10pt;">. This update requires lessees to recognize lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under previous authoritative guidance. The lease liability will be equal to the present value of lease payments and the right-of-use asset will be based on the lease liability, subject to adjustment for items such as initial direct costs. For income statement purposes, the new standard retains a dual model similar to Accounting Standards Codification, or ASC, 840, requiring leases to be classified as either operating or financing. For lessees, operating leases will result in straight-line expense (similar to current accounting by lessees for operating leases under ASC 840) while financing leases will result in a front-loaded expense pattern (similar to current accounting by lessees for capital leases under ASC 840). This update also introduces new disclosure requirements for leasing arrangements. The standard will become effective for the Company beginning January 1, 2019. Early adoption is permitted, although the Company does not expect to do so. The Company is currently evaluating the impact of ASU 2016-02 on its consolidated financial statements. For operating leases it will result in the recognition of lease liabilities and corresponding right-of-use assets upon adoption, which will have a material impact on the Company’s consolidated balance sheet. The Company does not believe the adoption of this ASU will have a significant impact on its consolidated statements of operations, stockholders’ equity or cash flows. At adoption, this update will be applied using a modified retrospective approach. Refer to Note 17, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Commitments and Contingencies</font><font style="font-family:inherit;font-size:10pt;">, for further discussion on the Company’s leases.</font></div><div style="line-height:120%;padding-top:0px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In June 2016, the FASB issued ASU 2016-13, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Financial Instruments—Credit Losses (Topic 326)</font><font style="font-family:inherit;font-size:10pt;">, which requires entities to measure all expected credit losses for financial assets held at the reporting date based on historical experience, current conditions and reasonable and supportable forecasts. Entities will now use forward-looking information to better form their credit loss estimates. This update also requires enhanced disclosures to help financial statement users better understand significant estimates and judgments used in estimating credit losses, as well as the credit quality and underwriting standards of an entity’s portfolio. This ASU will become effective for the Company beginning January 1, 2020, with early adoption permitted. The Company is currently evaluating the impact of ASU 2016-13 on its consolidated financial statements.</font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">In August 2016, the FASB issued ASU 2016-15, </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">Statement of Cash Flows (Topic 230): Classification of Certain Cash Receipts and Cash Payments</font><font style="font-family:inherit;font-size:10pt;">, which clarifies existing guidance on how companies present and classify certain cash receipts and cash payments in the statement of cash flows by addressing specific cash flow issues in an effort to reduce diversity in practice, including guidance on debt prepayment or extinguishment costs and contingent consideration payments made after a business combination. ASU 2016-15 will become effective for the Company in the first quarter of fiscal year 2018. The Company does not expect any changes to its consolidated statement of cash flows upon the adoption of this standard.</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div><div style="line-height:120%;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other pronouncements issued by the FASB or other authoritative accounting standards groups with future effective dates are either not applicable or not significant to the consolidated financial statements of the Company.</font></div></div>
CY2017	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-bottom:10px;padding-top:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">Use of Estimates</font></div><div style="line-height:120%;padding-bottom:10px;padding-top:10px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with GAAP requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, including disclosure of contingent assets and contingent liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Estimates are used for, among other things, revenue recognition, inventory costs, impairments of goodwill and long-lived assets, liabilities and accruals and the valuation of deferred tax assets. The Company’s critical accounting policies are those that are both most important to the Company’s consolidated financial condition and results of operations and require the most difficult, subjective or complex judgments on the part of management in their application, often as a result of the need to make estimates about the effect of matters that are inherently uncertain. Because of the uncertainty of factors surrounding the estimates or judgments used in the preparation of the consolidated financial statements, actual results could differ from these estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001396814-18-000009-index-headers.html	Edgar Link	pending
0001396814-18-000009-index.html	Edgar Link	pending
0001396814-18-000009.txt	Edgar Link	pending
0001396814-18-000009-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hcpvendorinsurance.jpg	Edgar Link	pending
item5colorcharta02.jpg	Edgar Link	pending
itemsremoved.jpg	Edgar Link	pending
paciralogoa05.jpg	Edgar Link	pending
pcrx-12312017x10k.htm	Edgar Link	pending
pcrx-12312017xex1014.htm	Edgar Link	pending
pcrx-12312017xex211.htm	Edgar Link	pending
pcrx-12312017xex231.htm	Edgar Link	pending
pcrx-12312017xex232.htm	Edgar Link	pending
pcrx-12312017xex311.htm	Edgar Link	pending
pcrx-12312017xex312.htm	Edgar Link	pending
pcrx-12312017xex321.htm	Edgar Link	pending
pcrx-12312017xex322.htm	Edgar Link	pending
pcrx-20171231.xml	Edgar Link	completed
pcrx-20171231.xsd	Edgar Link	pending
pcrx-20171231_cal.xml	Edgar Link	unprocessable
pcrx-20171231_def.xml	Edgar Link	unprocessable
pcrx-20171231_lab.xml	Edgar Link	unprocessable
pcrx-20171231_pre.xml	Edgar Link	unprocessable
premises.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PCRX
Pacira Biosciences Inc Stock $pcrx

2017 Form 10-K Financial Statement

#000139681418000009 Filed on February 28, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX Pacira Biosciences Inc Stock $pcrx

2017 Form 10-K Financial Statement

#000139681418000009 Filed on February 28, 2018

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PCRX
Pacira Biosciences Inc Stock $pcrx